IDA total vs Zimbabwe: Access to anti-retroviral drugs, female
IDA total
87.1%
in 2024
Zimbabwe
98.0%
in 2024
IDA total rank
4th
Zimbabwe rank
1st
Access to anti-retroviral drugs, female over time
- IDA total
- Zimbabwe
How they compare
Zimbabwe currently reports 98.0% against 87.1% in IDA total, a difference of 10.9%.
That makes Zimbabwe's figure about 1.1 times IDA total's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Zimbabwe ahead.
IDA total ranks 4th and Zimbabwe ranks 1st of 19 groups.
Across the 3 decades both report, IDA total averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | IDA total | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 4.3% | 1.2% | IDA total |
| 2010s | 48.9% | 63.8% | 14.9% | Zimbabwe |
| 2020s | 80.9% | 96.0% | 15.1% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, IDA total or Zimbabwe?
- Zimbabwe, at 98.0% against 87.1% in IDA total as of 2024.
- What is the difference in access to anti-retroviral drugs, female between IDA total and Zimbabwe?
- 10.9%, with Zimbabwe ahead.
- How many years of comparable data are there for IDA total and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA total and Zimbabwe rank globally for access to anti-retroviral drugs, female?
- IDA total ranks 4th and Zimbabwe ranks 1st of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.